Mylan claims Ranbaxy does not have the marketing rights nor the regulatory approval. Furthermore, previous decisions by the FDA is costing patients billions of dollars in savings…..
If you enjoy the content at iBankCoin, please follow us on TwitterRelated Articles
Don’t Do The Crime Unless You Can Pay the Fine
August 7, 2014
State of the Union: Hopes are Dashed
August 6, 2014
1 in 3 Americans are in Financial Ruin
July 29, 2014